Table 3 Factors associated with long-term stented-territory infarction in CAS

Age

0.96 (0.91–1.02)

0.163

Male sex

1.97 (0.25–15.5)

0.521

Hypertension

0.30 (0.09–1.07)

0.064

0.31 (0.08–1.16)

0.082

Diabetes

1.00 (0.28–3.55)

> 0.999

Hyperlipidemia

0.13 (0.02–0.99)

0.049

0.22 (0.03–1.86)

0.164

Coronary artery disease

0.85 (0.22–3.28)

0.812

Stroke history

1.48 (0.42–5.27)

0.541

HbA1c, %

0.98 (0.56–1.73)

0.949

LDL, mg/dL

1.00 (0.98–1.02)

0.934

ARU ≥550

0.49 (0.06–3.88)

0.501

PRU ≥275

1.99 (0.42–9.36)

0.385

% PI < 20%

0.90 (0.26–3.12)

0.873

Intracranial lesion

2.74 (0.58–12.9)

0.203

Symptomatic stenosis

0.52 (0.15–1.85)

0.313

Number of stents ≥2

3.19 (0.40–25.2)

0.271

Maximum diameter of stents, mm

0.64 (0.48–0.86)

0.003

0.95 (0.60–1.53)

0.847

Total length of stents, mm

0.93 (0.88–0.98)

0.009

0.96 (0.89–1.03)

0.276

Pre-ballooning dilatation

0.37 (0.10–1.43)

0.149

Post-ballooning dilatation

1.35 (0.39–4.68)

0.641

Maximum balloon pressure, atm

1.03 (0.83–1.29)

0.766

In-stent restenosis

24.3 (6.84–86.3)

< 0.001

15.1 (3.17–72.2)

< 0.001